Lacosamide isothiocyanate-based agents: novel agents to target and identify lacosamide receptors.
Lacosamide isothiocyanate-based agents: novel agents to target and identify lacosamide receptors.
复制标题
拉科酰胺异硫氰酸酯类药物:靶向和识别拉科酰胺受体的新型药物。
DOI:
10.1021/jm9012054
复制
发表时间:
2009
影响因子:
7.3
通讯作者:
Kohn,Harold
中科院分区:
文献类型:
--
作者:
Park,KiDuk;Morieux,Pierre;Salomé,Christophe;Cotten,StevenW;Reamtong,Onrapak;Eyers,Claire;Gaskell,SimonJ;Stables,JamesP;Liu,Rihe;Kohn,Harold
(R)-Lacosamide ((R)-2, (R)-N-benzyl 2-acetamido-3-methoxypropionamide) has recently gained regulatory approval for the treatment of partial-onset seizures in adults. Whole animal pharmacological studies have documented that (R)-2function is unique. A robust strategy is advanced for the discovery of interacting proteins associated with function and toxicity of (R)-2through the use of (R)-2analogues,3, which contain “affinity bait (AB)” and “chemical reporter (CR)” functional groups. In3, covalent modification of the interacting proteins proceeds at the AB moiety, and detection or isolation of the selectively captured protein occurs through the bioorthogonal CR group upon reaction with an appropriate probe. We report the synthesis, pharmacological evaluation, and interrogation of the mouse soluble brain proteome using3where the AB group is an isothiocyanate moiety. One compound, (R)-N-(4-isothiocyanato)benzyl 2-acetamido-3-(prop-2-ynyloxy)propionamide ((R)-9), exhibited excellent seizure protection in mice, and like (R)-2, anticonvulsant activity principally resided in the (R)-stereoisomer. Several proteins were preferentially labeled by (R)-9compared with (S)-9, including collapsin response mediator protein 2.